Centro Nacional de Biotecnologia

Agencia Estatal Consejo Superior de Investigaciones Científicas (CSIC), Centro Nacional de Biotecnología.

The Agencia Estatal Consejo Superior de Investigaciones Científicas (CSIC) is the largest public, multidisciplinary research organisation in Spain, with 126 Institutes centres distributed throughout Spain. CSIC has a wide experience in both participation and management of R&D projects and training grants. Under the 6th Framework Programme the CSIC has signed 418 contracts (37 coordinated by the CSIC).

The Centro Nacional de Biotecnología (CNB) is currently the largest centre of the CSIC, and was opened in 1992, to promote research in advanced biotechnology, and act as a connection between basic research and industrial applications.

Under the 6th Framework Programme, the CNB has signed 46 contracts, and at the moment under the 7th Framework Programme the CNB has already signed 19 projects. The greatest research efforts are focused in the areas of biomedicine, agriculture and environment.

There are specific projects on genomics and functional proteomics, the development of bio-computing tools, structural biology, particularly EM-based approaches, infectious and tumor-like diseases, the development of vectors for gene therapy, as well as vaccines for humans and farm animals, the development of plants resistant to stress, the construction of new microorganisms for environmental recovery, the production of antibiotics and hydrolytic enzymes, and the discovery of immuno-modulator compounds. At present, the CNB houses 539 researchers who published 196 articles in international indexed journals in 2008.

www.csic.es
www.cnb.csic.es

 

Juan Ortín | PhD (1971)

Current position: Group Leader at Centro Nacional de Biotecnología. With a basic training in Chemistry and Biology, he has 30 years experience in research on influenza viruses, particularly on virus genetic variation, replication and gene expression. He has participated to several EU projects included in the SCIENCE Programme, the HCM Programme and FP6 (VIRGIL and FLUPOL).